Boron-containing compounds: Chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy

Expert Opinion on Therapeutic Patents

Volumn 24, Issue 5, 2014, Pages 485-500

  Soriano Ursúa, Marvin A ^a   Das, Bhaskar C ^b   Trujillo Ferrara, José G ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Boron containing compounds; Diagnosis tools; Drug development; Human therapeutics; Toxicology

Indexed keywords

BORANE DERIVATIVE; BORINIC ACID DERIVATIVE; BORON; BORON CONTAINING COMPOUND; CARBORANE DERIVATIVE; ORGANOBORON DERIVATIVE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BORON DERIVATIVE;

BIOLOGICAL ACTIVITY; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; DISEASES; DRUG TOXICITY; HUMAN; PATENT; PHYSICAL CHEMISTRY; PREVENTIVE MEDICINE; REVIEW; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; BORON COMPOUNDS; HUMANS; PATENTS AS TOPIC; PREVENTIVE MEDICINE;

EID: 84899027969     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2014.881472     Document Type: Review

References (145)

1. Scorei R. Is boron a prebiotic element? A mini-review of the essentiality of boron for the appearance of life on earth. Orig Life Evol Biosph 2012;42:3-17
2. Tanaka M, Fujiwara T. Physiological roles and transport mechanisms of boron: perspectives from plants. Pflugers Arch 2008;456:671-7
3. Miwa K, Fujiwara T. Boron transport in plants: co-ordinated regulation of transporters. Ann Bot 2010;105:1103-8
4. Takano J, Miwa K, Fujiwara T. Boron transport mechanisms: collaboration of channels and transporters. Trends Plant Sci 2008;13:451-7
5. Nielsen FH. Boron in human and animal nutrition. Plant Soil 1997;193:199-208
6. Devirian TA, Volpe SL. The physiological effects of dietary boron. Crit Rev Food Sci Nutr 2003;43:219-31
7. Hunt CD. Dietary boron: progress in establishing essential roles in human physiology. J Trace Elem Med Biol 2012;26:157-60
8. Korkmaz M. Boron:environmental exposure and human health. Encyclopedia of environmental health. Elsevier, Inc; Amsterdam: 2011. p. 442-5
9. Hunter P. Not boring at all. Boron is the new carbon in the quest for novel drug candidates. EMBO Rep 2009;10:125-8
10. Soriano-Ursua MA, Mancilla-Percino T, Querejeta E, Trujillo-Ferrara JG. Give boron a chance: boron containing compounds reach ionotropic and metabotropic transmembrane receptors. Mini Rev Med Chem 2011;11:1031-8
11. Baker SJ, Ding CZ, Akama T, et al. Therapeutic potential of boron-containing compounds. Future Med chem 2009;1:1275-88
12. Ciani L, Ristori S. Boron as a platform for new drug design. Expert Opin Drug Discov 2012;7:1017-27
13. Das BC, Thapa P, Karki R, et al. Boron chemicals in diagnosis and therapeutics. Future Med Chem 2013;5:653-76
14. Camacho-Cristóbal JJ, Rexach J, González-Fontes A. Boron in plants: deficiency and toxicity. J Integr Plant Biol 2008;50:1247-55
15. Kohno J, Kawahata T, Otake T, et al. Boromycin, an anti-HIV antibiotic. Biosci Biotechnol Biochem 1996;60:1036-7
16. Benderdour M, Bui-Van T, Dicko A, Belleville F. In vivo and in vitro effects of boron and boronated compounds. J Trace Elem Med Biol 1998;12:2-7
17. Bernard CE, Harrass MC, Manning MJ. Boric acid and inorganic borate pesticides. Hayes handbook of pesticide toxicology. Elsevier, Inc.; Amsterdam: 2010. p. 2033-53
18. Bolt HM, Basaran N, Duydu Y. Human environmental and occupational exposures to boric acid: reconciliation with experimental reproductive toxicity data. J Toxicol Environ Health A 2012;75:508-14
19. Chapin RE, Ku WW, Kenney MA, et al. The effects of dietary boron on bone strength in rats. Fundam appl toxicol 1997;35:205-15
20. Hasbahceci M, Cipe G, Kadioglu H, et al. Reverse relationship between blood boron level and body mass index in humans: does it matter for obesity? Biol Trace Elem Res 2013;153:141-4
21. Pieczyńska J, Grajeta H, Weber R, Biernat J. Dietary carbohydrate content influences borons effect on lipid and protein indices in rats. Biol Trace Elem Res 2007;115:137-46
22. Caglar GS, Cakal GO, Yuce E, Pabuccu R. Evaluation of serum boron levels and lipid profile in pregnancies with or without gestational diabetes. J Perinat Med 2011;40:137-40
23. Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 2005;11:3987-4002
24. Moss RL. Critical review, with an optimistic outlook, on Boron Neutron Capture therapy (BNCT). Appl Radiat Isot 2013;doi:10.1016/j.apradiso.2013.11.109
25. Zhou HB, Nettles KW, Bruning JB, et al. Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands. Chem Biol 2007;14:659-69
26. Zhu Y, Siwei X, Maguire JA, Hosmane NS. Application of cycloaddition reactions to the syntheses of novel boron compounds. Molecules 2010;15:9437-49
27. Scorei RI, Popa R Jr. Boron-containing compounds as preventive and chemotherapeutic agents for cancer. Anticancer Agents Med Chem 2010;10:346-51
28. Trippier PC, McGuigan C. Boronic acids in medicinal chemistry: anticancer, antibacterial and antiviral applications. Med Chem Comm 2010;1:183-98
29. Guo Z, Shin I, Yoon J. Recognition and sensing of various species using boronic acid derivatives. Chem Commun (Camb) 2012;48:5956-7
30. Yang W, Gao X, Wang B. Boronic acids, preparation and application in organic chemistry and medicine. Willey-VCH; Germany: 2005. p. 481-512
31. University of Illinois. System for controlling the reactivity of boronic acids. US8318983; 2012
32. Universite De Nice Sophia Antipolis. Process for preparing boronic acids and esters in the presence of magnesium metal. US0184484; 2013
33. Duncan K, Faraci WS, Matteson DS, Walsh CT. (1-Aminoethyl)boronic acid: a novel inhibitor for Bacillus stearothermophilus alanine racemase and Salmonella typhimurium D-alanine: D-alanine ligase (ADP-forming). Biochemistry 1989;28:3541-9
34. Gorovoy AS, Gozhina O, Svendsen JS, et al. Syntheses and anti-tubercular activity of beta-substituted and alpha. beta-disubstituted peptidyl beta-aminoboronates and boronic acids. J Pept Sci 2013;19:613-18
35. Du Pont Pharm Co. Peptide boronic acid inhibitors of hepatitis c virus protease. WO002424; 2001
36. Dembitsky VM, Quntar AA, Srebnik M. Recent advances in the medicinal chemistry of alpha-aminoboronic acids, amine-carboxyboranes and their derivatives. Mini Rev Med Chem 2004;4:1001-18
37. Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use. US8106031; 2012
38. Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agent. US0231304; 2013
39. Fang H, Kaur G, Wang B. Progress in boronic acid-based fluorescent glucose sensors. J Fluoresc 2004;14:481-9
40. Jezierska A, Panek JJ, ZIùkowska GZ, SporzynIs̀ki A. A combined experimental and theoretical study of benzoxaborole derivatives by Raman and IR spectroscopy, static DFT, and first-principle molecular dynamics. J Phys Org Chem 2010;23:451-60
41. Trigen Ltd. Boronic acid salts useful in parenteral formulations. US0234228; 2008
42. Infinity Pharmaceuticals, Inc. Inhibitors of monoacylglycerol lipase and methods of their use. WO049332; 2013
43. Benkovic SJ, Baker SJ, Alley MR, et al. Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH. J Med Chem 2005;48:7468-76
44. Araujo-Alvarez JM, Trujillo-Ferrara JG, Ponce-Franco D, et al. (+)-(S)-trujillon, (+)-(S)-4-(2,2-diphenyl- 1,3,2-oxazabolidin-5-oxo)propionic acid, a novel glutamatergic analog, modifies the activity of globus pallidus neurons by selective NMDA receptor activation. Chirality 2011;23:429-37
45. Ono Pharmaceutical Co. Intracellular calcium concentration increase inhibitors. WO033002; 2003
46. Zhou H, Iwasaki H, Nakamura T, et al. 2-Aminoethyl diphenylborinate analogues: selective inhibition for storeoperated Ca2+ entry. Biochem Biophys Res Commun 2007;352:277-82
47. Burnham BS. Synthesis and pharmacological activities of amineboranes. Curr Med Chem 2005;12:1995-2010
48. Viñas C. The uniqueness of boron as a novel challenging element for drugs in pharmacology, medicine and for smart biomaterials. Future Med Chem 2013;5:617-19
49. Scholz M, Hey-Hawkins E. Carbaboranes as pharmacophores: properties, synthesis, and application strategies. Chem Rev 2011;111:7035-62
50. Shalom E; Soreq Nuclear Res Ct Israel At, Srebnik M, Takrouri Khuloud, Yissum Res Dev Co. Novel amine-borane compounds and uses thereof. WO032005; 2007
51. Jabbour A, Smoum R, Takrouri K, et al. Pharmacologically active boranes. Pure Appl Chem 2006;78:1425-53
52. Issa F, Kassiou M, Rendina LM. Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds. Chem Rev 2011;111:5701-22
53. Valliant JF, Guenther KJ, King AS, et al. The medicinal chemistry of carboranes. Coord Chem Rev 2002;232:173-230
54. Ian Flockhart, Bipin Patel, Psimei Pharmaceuticals Plc, Ken Rickwood. Therapeutic compositions comprising a boron-containing compound. WO030661; 2004
55. Calabrese G, Nesnas JJ, Barbu E, et al. The formulation of polyhedral boranes for the boron neutron capture therapy of cancer. Drug Discov Today 2012;17:153-9
56. Genady AR. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation. Eur J Med Chem 2009;44:409-16
57. Kultyshev RG, Liu J, Liu S, et al. S-alkylation and S-amination of methyl thioethers-derivatives of closo-[B(12)H (12)](2-). Synthesis of a boronated phosphonate, gem-bisphosphonates, and dodecaborane-ortho-carborane oligomers. J Am Chem Soc 2002;124:2614-24
58. Fujii S, Masuno H, Taoda Y, et al. Boron cluster-based development of potent nonsecosteroidal vitamin D receptor ligands: direct observation of hydrophobic interaction between protein surface and carborane. J Am Chem Soc 2011;133:20933-41
59. Hawkins PM, Jelliss PA, Nonaka N, et al. Permeability of the blood-brain barrier to a rhenacarborane. J Pharmacol Exp Ther 2009;329:608-14
60. Ohta K, Goto T, Fujii S, et al. Crystal structure, docking study and structureactivity relationship of carboranecontaining androgen receptor antagonist 3-(12-hydroxymethyl-1,12-dicarba-closododecaboran- 1-yl)benzonitrile. Bioorg Med Chem 2011;19:3540-8
61. Ohta K, Ogawa T, Endo Y. Estrogenic activity of B-fluorinated o-carborane- 1,2-bisphenol synthesized via S(N)Ar reaction. Bioorg Med Chem Lett 2012;22:4728-30
62. Scholz M, Kaluerović GN, Kommera H, et al. Carbaboranes as pharmacophores: similarities and differences between aspirin and asborin. Eur J Med Chem 2011;46:1131-9
63. Tiwari R, Mahasenan K, Pavlovicz R, et al. Carborane clusters in computational drug design: a comparative docking evaluation using AutoDock, FlexX, Glide, and Surflex. J Chem Inf Model 2009;49:1581-9
64. Neutron Therapies, Inc. Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors. EP0729363; 2003
65. Grimes RN. Carboranes. Academic Press; Amsterdam: 2011
66. Louie AS, Vasdev N, Valliant JF. Preparation, characterization, and screening of a high affinity organometallic probe for alpha-adrenergic receptors. J Med Chem 2011;54:3360-7
67. Calvaresi M, Zerbetto FJ. In silico carborane docking to proteins and potential drug targets. J Chem Inf Model 2011;51:1882-96
68. Boens N, Leen V, Dehaen W. Fluorescent indicators based on BODIPY. Chem Soc Rev 2012;41:1130-72
69. Lee JS, Kang NY, Kim YK, et al. Synthesis of a BODIPY library and its application to the development of live cell glucagon imaging probe. J Am Chem Soc 2009;131:10077-82
70. National University of Singapore. Bodipy structure fluorescence probes for diverse biological applications. WO095305; 2013
71. National University of Singapore. Bodipy structure fluorescence dye for neural stem cell probe. WO071012; 2012
72. Michigan Technological University. Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof. WO075514; 2010
73. Marks DL, Bittman R, Pagano RE. Use of Bodipy-labeled sphingolipid and cholesterol analogs to examine membrane microdomains in cells. Histochem Cell Biol 2008;130:819-32
74. Bezuglov VV, Gretskaya NM, Esipov SE, et al. Fluorescent-labeled lipophilic analogues of serotonin, dopamine, and acetylcholine: synthesis, mass spectrometry, and biological activity. Russ J Bioorg Chem 2004;30:459-65
75. Singh AP, Lee KM, Murale DP, et al. Novel sulphur-rich BODIPY systems that enable stepwise fluorescent O-atom turn-on and H2O2 neuronal system probing. Chem Commun (Camb) 2012;48:7298-300
76. Xu W, Kim TH, Zhai D, et al. Make caffeine visible: a fluorescent caffeine traffic light detector. Sci Rep 2013;3:2255
77. Yuan L, Lin W, Zheng K, et al. Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging. Chem Soc Rev 2013;42:622-61
78. Lee JJ, Lee SC, Zhai D, et al. Bodipy-diacrylate imaging probes for targeted proteins inside live cells. Chem Commun 2011;47:4508-10
79. Kim TI, Park J, Park S, et al. Visualization of tyrosinase activity in melanoma cells by a BODIPY-based fluorescent probe. Chem Commun (Camb) 2011;47:12640-2
80. Landrum M, Smertenko A, Edwards R, et al. BODIPY probes to study peroxisome dynamics in vivo. Plant J 2010;62:529-38
81. Liu S, Lin TP, Li D, et al. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/ fluorescence dual modality agents for tumor imaging. Theranostics 2013;3:181-9
82. Ojida A, Sakamoto T, Inoue MA, et al. Fluorescent BODIPY-based Zn(II) complex as a molecular probe for selective detection of neurofibrillary tangles in the brains of Alzheimers disease patients. J Am Chem Soc 2009;131:6543-8
83. Lee JS, Kim HK, Feng S, et al. Accelerating fluorescent sensor discovery: unbiased screening of a diversity-oriented BODIPY library. Chem Commun (Camb) 2011;47:2339-41
84. Lu J, Sun C, Chen W, et al. Determination of non-protein cysteine in human serum by a designed BODIPY-based fluorescent probe. Talanta 2011;83:1050-6
85. Li X, Cao JH, Li Y, et al. Activity-based probe for specific photoaffinity labeling gamma-aminobutyric acid B (GABAB) receptors on living cells: design, synthesis, and biological evaluation. J Med Chem 2008;51:3057-60
86. Han F, Xu Y, Jiang D, et al. A BODIPY-derived fluorescent probe for cellular pH measurements. Anal Biochem 2013;435:106-13
87. Khan TK, Broring M, Mathur S, Ravikanth M. Boron dipyrrin-prophirin conjugates. Coord Chem Rev 2013;257:2348-87
88. Barth RF, Yang W, Wu G, et al. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. Proc Natl Acad Sci USA 2008;105:17493-7
89. Liu JY, Huang Y, Menting R, et al. A boron dipyrromethene-phtalocyanine pentad as an artificial photosynthetic model. Chem Commun 2013;49:2998-3000
90. Heindel JJ, Price CJ, Schwetz BA. The developmental toxicity of boric acid in mice, rats, and rabbits. Environ health perspect 1994;102:107-12
91. Kucukkurt I, Akbel E, Karabag F, Ince S. The effects of dietary boron compounds in supplemented diet on hormonal activity and some biochemical parameters in rats. Toxicol Ind Health 2013;published online 04 January 2013; doi:10.1177/0748233712469648
92. Pahl M V, Culver BD, Vaziri ND. Boron and the kidney. J Ren Nutr 2005;15:362-70
93. Strong PL. Boric acid and inorganic borate pesticides. Handbook of pesticide toxicology. 2nd edition. Academic Press; San Diego: 2001. p. 1429-37
94. Koo MS, Ozawa T, Santos RA, et al. Synthesis and comparative toxicology of a series of polyhedral borane anionsubstituted tetraphenyl porphyrins. J Med Chem 2007;50:820-7
95. Soriano-Ursua MA, Farfán-García ED, López-Cabrera Y, et al. Boron-containing acids: preliminary evaluation of acute toxicity and access to the brain determined by Raman scattering spectroscopy. Neurotoxicology 2014;40:8-15
96. Weir RJ, Fisher RS. Toxicologic studies on borax and boric acid. Toxicol Appl Pharmacol 1972;23:351-64
97. Price CJ, Strong PL, Murray FJ, Goldberg MM. Blood boron concentrations in pregnant rats fed boric acid throughout gestation. Reprod toxicol 1997;11:833-42
98. ODonovan MR, Mee CD, Fenner S, et al. Boronic acids - a novel class of bacterial mutagen. Mutat Res 2011;724:1-6
99. Ciaravino V, Plattner J, Chanda S. An assessment of the genetic toxicology of novel boron-containing therapeutic agents. Environ Mol Mutagen 2013;54:338-46
100. Linden CH, Hall AH, Kulig KW, Rumack BH. Acute ingestions of boric acid. Clin Toxicol 1986;24:269-79
101. Litovitz TL, Klein-Schwartz W, Oderda GM, Schmitz BE. Clinical manifestations of toxicity in a series of 784 boric acid ingestions. Am J Emerg Med 1988;6:209-13
102. De Simone U, Manzo L, Ferrari C, et al. Short and long-term exposure of CNS cell lines to BPA-f a radiosensitizer for Boron neutron capture therapy: safety dose evaluation by a battery of cytotoxicity tests. Neurotoxicology 2013;35:84-90
103. Turkez H, Geyikoglu F, Tatar A, Keles MS. The effects of some boron compounds against heavy metal toxicity in human blood. Exp Toxicol Pathol 2012;64:93-101
104. Turkez H, Tatar A, Hacimuftuoglu A, Ozdemir E. Boric acid as a protector against paclitaxel genotoxicity. Acta Biochim Pol 2010;57:95-7
105. Alford R, Simpson HM, Duberman J, et al. Toxicity of organic fluorophores used in molecular imaging: literature review. Mol Imaging 2009;8:341-54
106. Protein Data Base. Available from: www. rcsb.org/pdb [Last accessed 23 December 2013]
107. Tamay-Cach F, Correa-Basurto J, Villa-Tanaca L, et al. Evaluation of new antimicrobial agents on Bacillus spp. strains: docking affinity and in vitro inhibition of glutamate-racemase. J Enzyme Inhib Med Chem 2013;28:1026-33
108. Ban HS, Usui T, Nabeyama W, et al. Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase. Org Biomol Chem 2009;7:4415-27
109. Soriano-Urs-ua MA, McNaught-Flores DA, Nieto-Alamilla G, et al. Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the human beta2-adrenoceptor. Bioorg Med Chem 2012;20:933-41
110. Transue TR, Gabel SA, London RE. NMR and crystallographic characterization of adventitious borate binding by trypsin. Bioconjug Chem 2006;17:300-8
111. Zervosen A, Herman R, Kerff F, et al. Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein. J Am Chem Soc 2011;133:10839-48
112. Eli Lilly And Co., Anacor Pharmaceuticals, Inc. Isoxazoline derivatives used in the control of ectoparasites. WO2013078071; 2013
113. Aziz-Ketuli K, Hadi AH. Boronate derivatives of Functionally diverse catechols: stability studies. Molecules 2010;15:2347-56
114. Ito Y, Mizuno T, Yoshino K, et al. Biological evaluation of dopamine analogues containing phenylboronic acid group as new boron carriers. Appl Radiat Isot 2011;69:1771-3
115. Sikora A, Zielonka J, Adamus J, et al. Reaction between peroxynitrite and triphenylphosphonium-substituted arylboronic acid isomers: identification of diagnostic marker products and biological implications. Chem Res Toxicol 2013;26:856-67
116. Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007;6:662-80
117. Er JC, Vendrell M, Tang MK, et al. Fluorescent dye cocktail for multiplex drug-site mapping on human serum albumin. ACS Comb Sci 2013;15:452-7
118. Lee SM, Choi NK, Lee BC, et al. Caffeine-containing medicines increase the risk of hemorrhagic stroke. Stroke 2013;44:2139-43
119. Baker JG, Adams LA, Salchow K, et al. Synthesis and characterization of highaffinity 4,4-difluoro-4-bora-3a,4a-diazas- indacene-labeled fluorescent ligands for human beta-adrenoceptors. J Med Chem 2011;54:6874-87
120. Wilbur DS, Chyan MK, Nakamae H, et al. Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closodecaborate( 2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-closodecaborate( 2-) reagent via lysine amines. Bioconjug Chem 2012;23:409-20
121. Dong H, Wang S, Galligan JJ, Swain GM. Boron-doped diamond nano/ microelectrodes for biosensing and in vitro measurements. Front Biosci (Schol Ed) 2011;3:518-40
122. Song MJ, Lee SK, Kim JH, Lim DS. Dopamine sensor based on a boron-doped diamond electrode modified with a polyaniline/Au nanocomposites in the presence of ascorbic acid. Anal Sci 2012;28:583-7
123. Dembitsky VM, Al Quntar AA, Srebnik M. Natural and synthetic small boron-containing molecules as potential inhibitors of bacterial and fungal quorum sensing. Chem Rev 2011;111:209-37
124. Betancort JM, Campbell DA, Hepperle ME, Winn DT; Phenomix Corp. Hepatitis C serine protease inhibitors and uses therefor. WO016476; 2007
125. Cheek MA, Dobrikov MI, Wennefors CK, et al. Synthesis and properties of (alpha-P-borano)-nucleoside 5-triphosphate analogues as potential antiviral agents. Nucleic Acids Symp Ser (Oxf) 2008;52:81-2
126. University of Tromso. Therapeutic boron-containing compounds. WO104897; 2013
127. Gen Hospital Corp. Xudong H. Bifunctional molecules comprising at least one integrin-binding and their use in imaging and therapy of angiogenesis and related disorders. WO069281; 2004
128. Di Costanzo L, Sabio G, Mora A, et al. Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response. Proc Natl Acad Sci USA 2005;102:13058-63
129. Freund YR, Akama T, Alley MR, et al. Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center. FEBS Lett 2012;586:3410-14
130. Li GW, Wang QS, Hao JH, et al. The functional expression of extracellular calcium-sensing receptor in rat pulmonary artery smooth muscle cells. J Biomed Sci 2011;18:16
131. Ma KT, Guan BC, Yang YQ, et al. 2-Aminoethoxydiphenyl borate blocks electrical coupling and inhibits voltage-gated K+ channels in guinea pig arteriole cells. Am J Physiol Heart Circ Physiol 2011;300:H335-46
132. Akama T, Virtucio C, Dong C, et al. Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent. Bioorg Med Chem Lett 2013;23:1680-3
133. Baker SJ, Akama T, Zhang YK, et al. Identification of a novel boroncontaining antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseases. Bioorg Med Chem Lett 2006;16:5963-7
134. Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents. US8039450; 2011
135. Anacor Pharmaceuticals, Inc. Boron-containing small molecules. WO028005; 2010
136. González AG, Zavala LC, Moreno AP, et al. Pharmacokinetics of diphenylboroxazolidones of L-alpha-amino acids with activity on the CNS: quantification in rat DBS by UPLC-MS/MS. Bioanalysis 2011;3:439-48
137. Pattzi HM, Pitale S, Alpizar M, et al. Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebocontrolled, multicentre trial. Diabetes Obes Metab 2010;12:348-55
138. Olgun O, Yazgan O, Cufadar Y. Effect of supplementation of different boron and copper levels to layer diets on performance, egg yolk and plasma cholesterol. J Trace Elem Med Biol 2013;27:132-6
139. Kamkaew A, Lim SH, Lee HB, et al. BODIPY dyes in photodynamic therapy. Chem Soc Rev 2013;42:77-88
140. Del Turco S, Ciofani G, Cappello V, et al. Cytocompatibility evaluation of glycol-chitosan coated boron nitride nanotubes in human endothelial cells. Colloids Surf B Biointerfaces 2013;111C:142-9
141. He L, Fullenkamp DE, Rivera JG, Messersmith PB. pH responsive self-healing hydrogels formed by boronate-catecholcomplexation. Chem Commun 2011;47:7497-9
142. Molecular Medicine Center. Diagnostic and therapeutic antibody conjugates. WO005031; 1987
143. McClary CA, Taylor MS. Applications of organoboron compounds in carbohydrate chemistry and glycobiology: analysis, separation, protection, and activation. Carbohydr Res 2013;381:112-22
144. Bregadze V, Semioshkin A, Sivaev I. Synthesis of conjugates of polyhedral boron compounds with tumor-seeking molecules for neutron capture therapy. Appl Radiat Isot 2011;69:1774-7
145. Stierand K, Rarey M. Drawing the PDB: protein-ligand complexes in two dimensions. Med Chem Lett 2010;1:540-5; 2010-Poseview